Brain Boost Program for Scleroderma

Recruiting in Palo Alto (17 mi)

Overseen by Yen Chen, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Michigan

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.

Research Team

Yen Chen, PhD

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for individuals with systemic sclerosis, a condition that involves hardening of the skin and connective tissues. Participants should be interested in improving their cognitive function and well-being through an online educational program.

Inclusion Criteria

Be able to read, speak, and understand English

A score of ≥ 10 on the Perceived Deficits Questionnaire

A score of ≤ 7 on the 6-Item Cognitive Impairment Test

Exclusion Criteria

Other neurological disorders that might impact cognition

Have major psychiatric disorder such as major depression and schizophrenia

I have been diagnosed with dementia or have had a head injury.

Treatment Details

Interventions

• Brain Boost Program (Behavioral Intervention)

Trial Overview The study is testing an 8-week 'Brain Boost' program designed to enhance cognitive abilities in people with systemic sclerosis. It compares outcomes between those who receive the intervention immediately and a waitlist group who do not.

Participant Groups

Group I: Waitlist group Experimental Treatment 1 Intervention

Group II: Brain Boost group Experimental Treatment 1 Intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

University of Michigan Ann Arbor, MI

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials

1891

Patients Recruited

6,458,000+

National Scleroderma Foundation

Collaborator

Trials

1

Patients Recruited

70+